Emerging Therapies in Multiple Sclerosis: Perspectives and Future

• Autor(a) principal: Andrade Trajano dos Santos , Maria Eduarda
• Data de Publicação: 2023
• Outros Autores: Silva Fideli, Gabriel, Rodrigues Marques Júnior, Walter, de Amorim Mendonça , Stéfany, Vilela Vargas, Conrado
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1014
• topic: Esclerose Múltipla; Terapias Emergentes; Personalização do Tratamento.

This research investigates the progression of emerging therapies in the treatment of multiple sclerosis (MS), emphasizing the significance of these approaches in managing this intricate neurological condition. Emerging therapies play a crucial role in the pursuit of more effective and targeted alternatives, surpassing conventional approaches to immunomodulation and symptomatic control. The comprehensive analysis of these options aims to provide healthcare professionals with a deep understanding of the latest and innovative strategies, taking into account factors such as disease progression and patients' quality of life. The determination of emerging therapies in MS is multifaceted, influenced by variables such as the patient's genetic profile, disease stage, and response to previous treatments. In this context, the comparative evaluation of different approaches, including advanced immunotherapies, cellular therapies, and genetic interventions, becomes imperative to ensure treatment effectiveness and minimize potential adverse effects. Furthermore, treating MS with emerging therapies represents a complex challenge that requires an integrated approach. This research explores various therapeutic modalities, from pharmacological interventions to non-pharmacological methods, with the aim of providing valuable insights to optimize MS management and enhance the quality of life for post-treatment patients. Understanding the complexities and nuances of these therapies is crucial to ensure comprehensive and personalized care for MS patients, highlighting the importance of a holistic approach in managing this neurodegenerative condition. Ultimately, this article aims to consolidate up-to-date information on emerging therapies in multiple sclerosis, providing a critical analysis of the available scientific literature. The goal is to contribute to the continuous development of clinical practices in this area, promoting the effectiveness of procedures and improving the quality of life for patients facing this challenging neurological condition.